Back to Search
Start Over
Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease.
- Source :
-
Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Jul 03; Vol. 30 (7), pp. 1220-1222. - Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1536-4844
- Volume :
- 30
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Inflammatory bowel diseases
- Publication Type :
- Report
- Accession number :
- 38588461
- Full Text :
- https://doi.org/10.1093/ibd/izae078